Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-01-05 to 2023-01-06
Current total value of award: $234.62
Description: 4559509709!QUILLIVANT XR ORAL SUSP 180ML 5MG/ML